JP2022523383A5 - - Google Patents
Info
- Publication number
- JP2022523383A5 JP2022523383A5 JP2021549941A JP2021549941A JP2022523383A5 JP 2022523383 A5 JP2022523383 A5 JP 2022523383A5 JP 2021549941 A JP2021549941 A JP 2021549941A JP 2021549941 A JP2021549941 A JP 2021549941A JP 2022523383 A5 JP2022523383 A5 JP 2022523383A5
- Authority
- JP
- Japan
- Prior art keywords
- hydrogen
- group
- disease
- pharmaceutically acceptable
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962811471P | 2019-02-27 | 2019-02-27 | |
| US62/811,471 | 2019-02-27 | ||
| PCT/US2020/019942 WO2020176652A1 (en) | 2019-02-27 | 2020-02-26 | Quinazolinone compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022523383A JP2022523383A (ja) | 2022-04-22 |
| JP2022523383A5 true JP2022523383A5 (https=) | 2023-03-06 |
| JP7597722B2 JP7597722B2 (ja) | 2024-12-10 |
Family
ID=72238692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021549941A Active JP7597722B2 (ja) | 2019-02-27 | 2020-02-26 | キナゾリノン化合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12454514B2 (https=) |
| EP (1) | EP3930837A4 (https=) |
| JP (1) | JP7597722B2 (https=) |
| KR (1) | KR20210139279A (https=) |
| CN (1) | CN113747943A (https=) |
| AU (1) | AU2020228374A1 (https=) |
| CA (1) | CA3131294A1 (https=) |
| IL (1) | IL285805A (https=) |
| WO (1) | WO2020176652A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024033374A1 (en) | 2022-08-11 | 2024-02-15 | Syngenta Crop Protection Ag | Novel arylcarboxamide or arylthioamide compounds |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07107056B2 (ja) * | 1987-01-30 | 1995-11-15 | 日清製粉株式会社 | ４（３ｈ）−キナゾリノン誘導体、その製造方法およびそれを有効成分とする抗潰瘍剤 |
| US7381730B2 (en) * | 2002-03-15 | 2008-06-03 | Bristol-Myers Squibb Company | 3-arylquinazoline derivatives as selective estrogen receptor beta modulators |
| US20050038051A1 (en) * | 2003-06-09 | 2005-02-17 | Jodi Nunnari | Novel molecules for regulating cell death |
| US9492450B2 (en) * | 2011-04-19 | 2016-11-15 | University of Pittsburgh—of the Commonwealth System of Higher Education | Inhibition of dynamin related protein 1 to promote cell death |
| WO2013025508A1 (en) * | 2011-08-12 | 2013-02-21 | Southern Research Institute | Quinazolinone analogs and use of quinazolinone analogs for treating or preventing certain viral infections |
| JP2013142070A (ja) | 2012-01-11 | 2013-07-22 | Nihon Univ | ミトコンドリア分裂阻害剤を用いたｔｒａｉｌ抵抗性の克服 |
| CN111372921B (zh) * | 2017-09-13 | 2023-12-01 | 赛勒佩特公司 | 小分子化合物 |
| US11559527B2 (en) | 2017-12-20 | 2023-01-24 | Lunella Biotech, Inc. | Targeting mitochondrial fission through mDIVI-1 derivatives |
| US20190307749A1 (en) * | 2018-04-10 | 2019-10-10 | Texas Tech University System | Mitochondria-Division Inhibitor 1 Protects Against Amyloid-B Induced Mitochondrial Fragmentation and Synaptic Damage in Alzheimer's Disease |
-
2020
- 2020-02-26 KR KR1020217030721A patent/KR20210139279A/ko active Pending
- 2020-02-26 WO PCT/US2020/019942 patent/WO2020176652A1/en not_active Ceased
- 2020-02-26 CA CA3131294A patent/CA3131294A1/en active Pending
- 2020-02-26 EP EP20763727.3A patent/EP3930837A4/en active Pending
- 2020-02-26 JP JP2021549941A patent/JP7597722B2/ja active Active
- 2020-02-26 US US17/434,145 patent/US12454514B2/en active Active
- 2020-02-26 CN CN202080030788.4A patent/CN113747943A/zh active Pending
- 2020-02-26 AU AU2020228374A patent/AU2020228374A1/en not_active Abandoned
-
2021
- 2021-08-23 IL IL285805A patent/IL285805A/en unknown